MMP2 and B-cell non-Hodgkin lymphoma: Consistent with this data, significant increases in mRNA levels of MMP2 and MMP9 were observed in the cells treated with TEXs compared with untreated cells (Fig. 6f), suggesting that B cell lymphoma-derived EXOs play a critical role in triggering invasion of human normal cells via the activation of MMP molecules.